# Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in End Stage Renal Disease (ESRD)

> **NCT01017627** · NA · UNKNOWN · sponsor: **Fresenius Medical Care North America** · enrollment: 1500 (estimated)

## Conditions studied

- Anemia
- Mortality

## Interventions

- **OTHER:** Early anemia diagnosis and treatment
- **OTHER:** No change from normal routine

## Key facts

- **NCT ID:** NCT01017627
- **Lead sponsor:** Fresenius Medical Care North America
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-11
- **Primary completion:** 2010-11
- **Final completion:** 2010-12
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2010-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01017627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01017627, "Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in End Stage Renal Disease (ESRD)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01017627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*